Keir Starmer has been mocked for claiming he was too distracted by foreign affairs to realise he was facing a huge Labour rebellion over welfare cuts. The prime minister has held his hands up to a ...

Gilead officials lauded the FDA's approval of lenacapavir, which has been studied and developed over nearly two decades. "We now have a very real opportunity to end the HIV epidemic," said Daniel ...

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

Here’s what everyone should know about this new HIV prevention shot Yeztugo, a twice-a-year shot approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

HIV is the acronym for human immunodeficiency virus. HIV can only spread through bodily fluids like breast milk, blood, semen, pre-cum, rectal fluids, and vaginal fluids. The initial symptoms of ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of ...